baber/WOPTO huggingface dataset:
Patent MY-113797-A (MY)
Title: 14alpha, alpha 17 -c2-bridged norprogesterone derivatives
Inventor: DR HANS-PETER MUHN
IPC: C07J71/00
Filed: 1995-12-23
Abstract: THE INVENTION DESCRIBES 14,17-C2-BRIDGED STEROIDS OF GENERAL FORMULA (I), IN WHICHR3 STANDS FOR AN OXYGEN ATOM, THE HYDROXYIMINO GROUP OR TWO HYDROGEN ATOMS,R6 STANDS FOR A HYDROGEN, FLUORINE, CHLORINE OR BROMINE ATOM OR R6 STANDS FOR A C1-C4 ALKYL RADICAL IN A- ORb-POSITION, AND THEN R6'' AND R7 REPRESENT HYDROGEN ATOMS, OR ELSER6'' STANDS FOR A HYDROGEN, FLUORINE, CHLORINE OR BROMINE ATOM OR R6'' STANDS FOR A C1-C4 ALKYL RADICAL, AND THENR6'' AND R7 REPRESENT A COMMON ADDITIONAL BOND, R7 STANDS FOR A C1-C4 ALKYL RADICAL IN a - OR b-POSITION, AND THEN R6 AND R6'' REPRESENT HYDROGEN ATOMS, OR ELSER6 AND R7 TOGETHER STAND FOR A METHYLENE GROUP IN a- OR b- POSITION AND R6'' STANDS FOR A HYDROGEN ATOM ORR6 AND R6'' TOGETHER STAND FOR AN ETHYLENE OR METHYLENE GROUP, AND R7 STANDS FOR A HYDROGEN ATOM,R11 AND R12 EACH STAND FOR A HYDROGEN ATOM OR A COMMON BOND,R13 STANDS FOR A METHYL OR ETHYL GROUP,RI5 STANDS FOR A HYDROGEN ATOM OR A C1-C3 ALKYL RADICAL,R16 AND R16'' , INDEPENDENTLY OF ONE ANOTHER, STAND FOR A HYDROGEN ATOM, A C1-C3 ALKYL RAD<CAL OR A C2-C4 ALKENYL RADICAL OR TOGETHER FOR A C1-C3 ALKYLIDENE GROUP,R15 AND R16 STAND FOR A COMMON BOND AND R16'' STANDS FOR A HYDROGEN ATOM OR A C1-C3 ALKYL RADICAL ORR15 AND R16 TOGETHER STAND FOR A RING OF PARTIAL FORMULA IN WHICH N = 1 AND 2 AND X MEANS A METHYLENE GROUP OR AN OXYGEN ATOM, AND RI6'' STANDS FOR A HYDROGEN ATOM,R171 STANDS FOR A HYDROGEN ATOM OR A C2-C3 ALKYL RADICAL,R172 STANDS FOR A HYDROGEN ATOM, A C2-C3 ALKYL RADICAL OR A C2-C4 ALKENYL RADICAL,
Patent MY-113440-A (MY)
Title: Oral 2-methyl-thieno-benzodiazepine formulation
Inventor: GEORGE RANDALL COCHRAN
IPC: A61K9/28
Filed: 1996-03-22
Abstract: THE INVENTION PROVIDES A PHARMACEUTICALLY ELEGANT SOLID ORAL FORMULATION OF OLANZAPINE AND A PROCESS FOR MAKING SUCH FORMULATION.
Patent MY-126561-A (MY)
Title: A personal information management system
Inventor: PHILIPSON LARS
IPC: H04W88/02
Filed: 1998-11-20
Abstract: A PERSONAL INFORMATION MANAGEMENT SYSTEM, COMPRISING AT LEAST A PERSONAL INFORMATION MANAGER (1), INCLUDING FIRST TRANSCEIVER MEANS (32) AND FIRST STORAGE MEANS (30) FOR PERSONAL INFORMATION, AND AT LEAST A COMMUNICATION SYSTEM (2), INCLUDING SECOND STORAGE MEANS FOR PERSONAL INFORMATION, CONNECTED TO SECOND TRANSCEIVER MEANS (2'' ), HAS A BI-DIRECTIONAL LINK (3) BETWEEN SAID FIRST AND SECOND TRANSCEIVER MEANS FOR AUTOMATIC INFORMATION EXCHANGE BETWEEN SAID SYSTEM (2) AND SAID INFORMATION MANAGER (1), WHENEVER SAID SYSTEM (2) AND INFORMATION MANAGER (1) ARE WITHIN THE RANGE OF SAID LINK (3).(FIG. 1).
Patent MY-133290-A (MY)
Title: Apparatus for applying mortar or conncrete to a surface by spraying
Inventor: GOH CHUA WOO
IPC: E04C5/00
Filed: 2000-06-14
Abstract: THERE IS DISCLOSED AN APPARATUS FOR APPLYING MORTAR, CONCRETE MIXTURE OR THE LIKE TO A SURFACE BY SPRAYING. THE APPARATUS UTILIZES SQUEEZE-TYPE PUMP TO DELIVIER MORTAR OR CONCRETE MIXTURE TO ITS SPRAYING-NOZZLE (5). THE APPARATUS COMPRISES A MIXING MEANS (1) FOR MIXING MORTAR OR CONCRETE TO FORM SLURRY OF THE SAME, A FILTERING MEANS (2) FOR FILTERING THE FORMED SLURRY, AN EXTRUDING MEANS (3) INCLUDING A DELIVERY TUBE (4) TO DELIVIER THE SLURRY TO ITS SPRAYING-NOZZLE (5), AND A COMPRESSED AIR FEEDING MEANS (6) THAT IN COMBINATION WITH SAID SPRAYING-NOZZLE (5) ADAPTED TO DISCHARGE THE FORMED SLURRY ONTO THE DESIRED SURFACES. SUCH APPARATUS PROVIDES HIGHLY DEPENDABLE SPRAYING MACHINE THAT IS MORE RELIABLE, LESS WEAR AND TEAR OF THE AFFACTED PARTS AND COMPLETE SOLUTION FOR PLASTERING, BRICK AND ROOF TOP WATER-PROOFING WORK.(FIG 1)
Patent MY-133995-A (MY)
Title: 6-phenylpyrrolopyrimidinedione derivatives
Inventor: ARMANDO VEGA NOVEROLA
IPC: A61P15/10
Filed: 2001-06-06
Abstract: THE INVENTION RELATES TO NEW 6-PHENYLPYRROLOPYRIMIDINE DERIVATIVES OF FORMULA (I):@@@@(I)@WHEREIN -X-C-Y-REPRESENTS@@@OR-X-C-Y- REPRESENTS@@@AND TO THEIR USE AS SELECTIVE CYCLIC GMP SPECIFIC PHOSPHODIESTERASE (PDE 5) INHIBITORS, PROCESSES FOR PRODUCING THEM, INTERMEDIATED USED IN THEIR PRODUCTION, COMPOSITION CONTAINING THEM AND THEIR APPLICABILITY IN MEDICAL TREATMENT OF THE HUMAN OR ANIMAL BODY.
Patent MY-128512-A (MY)
Title: Semiconductor device
Inventor: AZAMI MUNEHIRO
IPC: G09G3/20
Filed: 2002-04-17
Abstract: THERE IS PROVIDED A SEMICONDUCTOR DEVICE IN WHICH FABRICATION STEPS CAN BE REDUCED BY CONSTRUCTING A CIRCUIT USING ONLY TFTS OF ONE CONDUCTIVITY TYPE AND IN WHICH A VOLTAGE AMPLITUDE OF AN OUTPUT SIGNAL CAN BE NORMALLY OBTAINED. A CAPACITANCE (205) IS PROVIDED BETWEEN A GATE AND A SOURCE OF A TFT (203) CONNECTED TO AN OUTPUT NODE, AND A CIRCUIT FORMED OF TFTS (201) AND (202) HAS A FUNCTION TO BRING A NODE A INTO A FLOATING STATE. WHEN THE NODE A IS IN THE FLOATING STATE, A POTENTIAL OF THE NODE A IS CAUSED HIGHER THAN VDD BY USING GATE-SOURCE CAPACITANCE COUPLING OF THE TFT (203) THROUGH THE CAPACITANCE (205), THUS AN OUTPUT SIGNAL HAVING AN AMPLITUDE OF VDD-GND CAN BE NORMALLY OBTAINED WITHOUT CAUSING AMPLITUDE ATTENUATION DUE TO THE THRESHOLD VALUE OF THE TFT. (FIG. 2A)
Patent MY-122882-A (MY)
Title: Arrangements of interconnect circuit and fluid drop generators.
Inventor: ROBERT N K BROWNING
IPC: B41J2/175
Filed: 2002-09-25
Abstract: AN INK JET PRINT CARTRIDGE (11) HAVING A COMPACT ELECTRICAL INTERCONNECT STRUCTURE THAT INCLUDES A PLURALITY OF PAIRS OF COLUMNAR ARRAYS (73) OF ELECTRICAL CONTACT AREAS DISPOSED ON A REAR WALL (24) OF THE PRINT CARTRIDGE AND ELECTRICALLY CONNECTED TO INK DROP GENERATORS (40) ARRANGED IN PRIMITIVE GROUPS. @@FIG. 6
Patent MY-151013-A (MY)
Title: Dosage forms and compositions for osmotic delivery of variable dosages of oxycodone
Inventor: FINK TRACY
IPC: A61K9/00
Filed: 2003-05-30
Abstract: DOSAGE FORMS, COMPOSITIONS AND METHODS FOR THE CONTROLLED RELEASE OF OXYCODONE OVER A PROLONGED PERIOD OF TIME ARE DESCRIBED. THE PRESENT INVENTION DISCLOSES A NOVEL MEANS FOR DELIVERING VARYING DOSES OF OXYCODONE USING A DRUG COMPOSITION HAVING ONLY OXYCODONE, A POLYMER CARRIER AND VARYING AMOUNTS OF SALT TO PROVIDE A PARTICULAR VISCOSITY OF THE HYDRATED DRUG CORE FOR DELIVERY OF THE DRUG AT THE DESIRED RELEASE RATE. THE PRESENT INVENTION FUNCTIONS BY MODULATING THE VISCOSITY OF THE HYDRATED DRUG LAYER IN OPERATION BY THE ADDITION OR REDUCTION OF SALTS IN THE DRUG COMPOSITION. THE SYSTEM IS INDEPENDENT OF SOLUBILITY ENHANCERS OF pH MODIFIERS. THE SUSTAINED RELEASE DOSAGE FORMS PROVIDE THERAPEUTICALLY EFFECTIVE AVERAGE STEADY-STATE PLASMA OXYCODONE CONCENTRATIONS WHEN ADMINISTERED ONCE PER DAY. THE MOAST ILLUSTRATIVE DRAWING IS
Patent MY-142346-A (MY)
Title: Medicament and method for reducing alcohol and/or tobacco consumption
Inventor: MOORMAN JOACHIM
IPC: A61K31/55
Filed: 2003-08-01
Abstract: THE PRESENT INVENTION RELATES TO A MEDICAMENT FOR TREATING ADDICTION CRAVING WHICH IS CHARACTERIZED IN THAT THE MEDICAMENT CONSISTS OF A COMBINATION OF TWO ADMINISTRATION FORMS, ONE OF THE ADMINISTRATION FORMS CONTINUOUSLY RELEASING AT LEAST ONE MODULATOR OF NICOTINIC RECEPTORS AND THE OTHER ADMINISTRATION FORM ENABLING A RAPID ENTRY OF GALANTHAMINE INTO THE CENTRAL NERVOUS SYSTEM, AS WELL AS A TWOSTAGE METHOD FOR THE THERAPY OF SUBSTANCE CRAVING THROUGH MODULATION OF NEURONAL NICOTINIC RECEPTORS, WHEREIN A PERMANENT TREATMENT WITH A PHARMACEUTICAL ADMINISTRATION FORM WHICH CONTINUOUSLY DELIVERS A MODULATOR OF NICOTINIC RECEPTORS IS SUPPLEMENTED UPON THE APPEARANCE OF A STRONG CRAVING FOR A SUBSTANCE BY ADMINISTERING GALANTHAMINE OR A PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF BY MEANS OF AN ADMINISTRATION.FORM WHICH ENABLES RAPID ENTRY OF THIS MODULATOR INTO THE CENTRAL NERVOUS SYSTEM.
Patent MY-136657-A (MY)
Title: Heterogeneously catalyzed partial gas phase oxidation of propene to acrolein
Inventor: DIETERLE MARTIN DR
IPC: C07C45/35
Filed: 2004-02-20
Abstract: IN A PROCESS FOR HETEROGENEOUSLY CATALYZED PARTIAL GAS PHASE OXIDATION OF PROPENE TO ACROLEIN, THE STARTING REACTION GAS MIXTURE IS OXIDIZED AT A PROPENE LOADING OF < 160 (STP) OF PROPENE/ OF FIXED CATALYST BED H OVER A FIXED CATALYST BED WHICH IS ACCOMMO-DATED IN TWO SUCCESSIVE REACTION ZONES A, B, THE HIGHEST TEMPERATURE OF THE REACTION GAS MIXTURE WITHIN REACTION ZONE A BEING ABOVE THE TEMPERATURE OF THE REACTION GAS MIXTURE WITHIN REACTION ZONE B.
Patent MY-160857-A (MY)
Title: A cancer vaccine
Inventor: DR KALANITHI NESARETNAM
IPC: C12N5/09
Filed: 2006-02-03
Abstract: THE PRESENT INVENTION RELATES TO A METHOD FOR PRODUCING A COMPOSITION FOR USE AS A VACCINE FOR TREATMENT OR PREVENTION OF CANCER. THE METHOD INCLUDES THE STEPS OF ISOLATING DENDRITIC CELLS FROM A BLOOD, BONE MARROW OR OTHER TISSUE SAMPLE OF A PATIENT SUFFERING FROM CANCER OR FROM AN UNRELATED DONOR, CULTURING THE DENDRITIC CELLS UNDER CONDITIONS AND PULSING THE DENDRITIC CELLS WITH TUMOUR CELL LYSATE OR AN ANTIGEN RELEASED BY THE TYPE OF TUMOUR CELL AND A TOCOTRIENOL.
Patent MY-146142-A (MY)
Title: Authentication of data transmitted in a digital transmission system
Inventor: BEUOUE JEAN-BERNARD GERARD MAURICE
IPC: H04H20/00
Filed: 2001-04-03
Abstract: A METHOD OF AUTHENTICATING DATA TRANSMITTED IN A DIGITAL TRANSMISSION SYSTEM, IN WHICH THE METHOD COMPRISES THE STEPS, PRIOR TO TRANSMISSION, OF DETERMINING AT LEAST TWO ENCRYPTED VALUES (146) FOR AT LEAST SOME OF THE DATA (134), EACH ENCRYPTED VALUE BEING DETERMINED USING A KEY OF A RESPECTIVE ENCRYPTION ALGORITHM, AND OUTPUTTING SAID AT LEAST TWO ENCRYPTED VALUES (146) WITH SAID DATA (134).
Patent MY-143304-A (MY)
Title: System and method for managing objects according to the common information model
Inventor: JIANWEN YIN
IPC: G06F17/30
Filed: 2007-03-23
Abstract: A SYSTEM AND METHOD IS DISCLOSED FOR MANAGING OBJECLS IN ACCORDANCE WITH THE COMMON INFORMATION MODEL. THE SYSTEM AND METHOD DISCLOSED HEREIN INCLUDES AN ABSTRACT LAYER THAT RECEIVES REQUESTS FROM THE CIM CLIENTS TBROUGH THE CIM OBJECT MANAGER. AFTER THE RECEIPT OF A REQUEST, THE ABSTRACT LAYER RETRIEVES THE ASSOCIATED XMIL REGISTRATION FILE FOR THE GENERATION OF A COMMAND TO THE MANAGED OBJECT THAT IS THE TARGET OF THE REQUEST. AFTER THE COMMAND IS EXECUTED WITH RESPECT TO THE MANAGED OBJECT, THE REQUESTED DATA IS RETURNED TO THE ABSTRACT LAYER THE DATA RETURNED LO THE ABSTRACT LAYER IS IN THE FORM OF UNTRANSFORMED XMI- CONTENT. THE ABSTRACT LAYER RETRIEVES AN XSL TRANSFORMATION FILE AND TRANSFORMS THE XML CONTENT INTO AN INSTANCE OF CDATA AND TRANSFERS THIS DATA TO THE CIM OBJECT MANAGER.
Patent MY-160651-A (MY)
Title: Head massager and a distance adjust device
Inventor: WU XU LIANG
IPC: A61H1/00
Filed: 2008-03-26
Abstract: A HEAD MASSAGER INCLUDES A HELMET (10) HAVING A FIRST ARE MEMBER (11) AND A SECOND ARE MEMBER (12) CONNECTED TO EACH OTHER FOR FORMING A RING SURROUNDING THE USER'S HEAD. THE HELMET (10) HAS A FIRST CURVED MEMBER (21) AND A SECOND CURVED MEMBER (22) CONNECTED TO EACH OTHER TO FORM AN ARC STRUCTURE AND HANG THE HEAD MASSAGER ON USER'S HEAD. THE DISTANCE ADJUSTMENT DEVICES (3) ARE PROVIDED TO CONNECT THE FIRST PARALLEL HOOP (11), THE SECOND PARALLEL HOOP (12), THE FIRST CURVED MEMBER (21) AND THE SECOND CURVED MEMBER (22), TOGETHER FOR ADJUSTING THE SIZE OF THE HELMET (10) TO PROVIDE A COMFORTABLE FIT TO USER'S HEAD.
Patent MY-144795-A (MY)
Title: Method of reproducing data from information storage medium
Inventor: LEE KYUNG-GEUN
IPC: G11B15/52
Filed: 2005-02-25
Abstract: AN INFORMATION STORAGE MEDIUM ON WHICH DATA IS RECORDED AFTER PERFORMING OPTIMUM POWER CONTROL (OPC) AND A METHOD AND APPARATUS TO RECORD/REPRODUCE DATA ON/FROM THE INFORMATION STORAGE MEDIUM (D), WHEREIN THE RECORDABLE INFORMATION STORAGE MEDIUM HAS A PLURALITY OF RECORDING LAYERS (L0, L1, L2) AND A PICKUP (50) IRRADIATES A BEAM ONTO THE INFORMATION STORAGE MEDIUM, UTILIZE OPERATIONS OF: RECORDING DATA ON AT LEAST A PORTION OF A RECORDING LAYER THROUGH WHICH A TEST BEAM TO FIND AN OPTIMUM RECORDING POWER PASSES BEFORE PERFORMING OPTIMUM POWER CONTROL (OPC) ON A DESIRED RECORDING LAYER AND PERFORMING OPC ON THE DESIRED RECORDING LAYER. THE METHOD AND APPARATUS ALLOW DATA TO BE RECORDED AFTER PERFORMING A TEST TO DETERMINE AN OPTIMUM RECORDING POWER, THUS PROVIDING EFFECTIVE RECORDING/REPRODUCING QUALITY.
Patent MY-154502-A (MY)
Title: Reinforced hose
Inventor: ARON WITZ JOEL
IPC: F16L11/08
Filed: 2007-08-10
Abstract: A HOSE (10) COMPRISING A TUBULAR BODY (12) OF FLEXIBLE MATERIAL ARRANGED BETWEEN AN INNER AND AN OUTER HELICALLY WOUND WIRE (22,24). THE HOSE (10) FURTHER COMPRISES AN ELONGATE MEMBER (130) HAVING OPPOSING LONGITUDINAL EDGES, THE ELONGATE MEMBER BEING HELICALLY WOUND AROUND THE TUBULAR BODY SUCH THAT THE OPPOSING LONGITUDINAL EDGES OF THE LAYER ARE IN AN ADJACENT OR OVERLAPPING ARRANGEMENT, WHEREIN EACH LONGITUDINAL EDGE INCLUDES A FORMATION CAPABLE OF INTERENGAGING WITH A COOPERATING FORMATION ON THE OPPOSING LONGITUDINAL EDGE, WHEREIN THE ELONGATE MEMBER IS PROVIDED AT LEAST ONE REINFORCING MEMBER (135) WHICH EXTENDS ALONG THE LONGITUDINAL AXIS OF THE ELONGATE MEMBER.
Patent MY-157176-A (MY)
Title: Tamper-evident container
Inventor: KAM CHUA YUEN
IPC: B65D43/20
Filed: 2009-04-02
Abstract: A TAMPER-EVIDENT CONTAINER IS DISCLOSED COMPRISING A BODY 10 AND A SLIDABLE LID 40 COMPLEMENTARY TO COVER BODY OPENING 20. THE BODY OPENING 20 COMPRISES A PERIPHERAL FLANGE 12 EXTENDING ALONG OPPOSING LONGITUDINAL WALLS OF THE BODY 10. THE SLIDABLE LID 40 COMPRISES A PLURALITY OF U-SHAPE FLANGES 45 SLIDABLY FITTING OVER THE PERIPHERAL FLANGE 12. A LOCKING CHAMBER 33 IS COMPLEMENTARILY FORMED BY AND MUTUALLY PROVIDED ON EACH OF THE BODY 10 AND SLIDABLE LID UPON COMPLETE CLOSURE OF THE BODY OPENING 20 BY THE SLIDABLE LID 40, WHEREUPON A SLOT IS FORMED BY THE COMPLEMENTARY MATCHING PARTS OF THE CONTAINER BODY 10 AND LID 40 FOR INSERTION OF A TAMPER-EVIDENT SEAL (NOT SHOWN), SUCH AS ONE WITH A FRANGIBLE PORTION WHICH MAY BE IRREVERSIBLY INSERTED THROUGH THE SLOT TO LOCK THE SLIDABLE LID 40 ONTO THE BODY 10. A PLURALITY OF RIBS 46 PROTRUDES FROM THE UNDERSIDE OF THE SLIDABLE LID 40 SUCH THAT UPON CLOSURE OF THE OPENING 20, THE RIBS 46 ARE ADJACENT INSIDE OF, OR ABUTTING, THE BODY WALL. THE RIBS 46 SERVE TO PREVENT INWARD BENDING OR FLEXURE OF THE WALL DUE TO EXTERNAL PRESSURE EXERTING AGAINST THE WALL IN A TAMPERING ATTEMPT.
Patent MY-158026-A (MY)
Title: Crystal modifications-3-(1h-indol-3-yl)-4-[2-(4-methyl-piperazin-1-yl)-quinazolin-4-yl]-pyrrole-2, 5-dione
Inventor: PIOTR KARPINSKI
IPC: C07D403/14
Filed: 2007-10-18
Abstract: CRYSTAL MODIFICATIONS -3- (IH-INDOL-3-YL) -4- [2- (4-METHYL- PIPERAZIN-1-YL) -QUINAZOLIN-4-YLI -PYRROLE-2,5-DIONE 5 THE INVENTION RELATES TO A NEW CRYSTALLINE FORM OF THE ACETATE SALT OF, 3-(L.H.- INDOL-3-YL)-4-[2-(4-RNETHYL-PIP@ERAZIN-1-YL)-QUINAZOLIN-4-YL]-PYRROLE-2,5-DIONE, WHICH MAY BE USED FOR EXAMPLE FOR TRANSPLANTATION. I
Patent MY-158096-A (MY)
Title: Herbicidial synergistic composition
Inventor: RUDIGER KOTZIAN GEORG
IPC: A01N37/22
Filed: 2007-10-25
Abstract: 27 HERBICIDAL SYNERGISTIC COMPOSITION ABSTRACT THE PRESENT INVENTION RELATES TO THE USE OF (I) A COMPOUND OF FORMULA 1, WHEREIN M, N, R 5 AND S ARE AS DEFINED IN THE CLAIMS, TO SYNERGISTICALLY ENHANCE THE HERBICIDAL ACTIVITY OF A COMPOSITION COMPRISING PRETILACHLOR, AND TO THE USE OF PRETILACHOR TO SYNERGISTICAFLY ENHANCE THE HERBICIDAL ACTIVITY OF U COMPOSITION COMPRISING A COMPOUND OF FORMULA (1). THE INVENTION THUS EXTENDS TO NOVEL HERBICIDAL SYNERGISTIC COMPOSITIONS COMPRISING AS ACTIVE INGREDIENTS (I) A COMPOUND OF FORMULA I AND (II) A SYNERGISTICALLY EFFECTIVE AMOUNT IO OF PREFILACBLOR. THE INVENTION ALSO RELATES TO SUCH COMPOSITIONS WHEN FORM ULATED, AS WELL AS THE USE OF SUCH COMPOSITIONS AND FORMULATIONS IN THE CONTROL OF UNDESIRED PLANT GROWTH IN CROPS OF USEFUL PLANTS. OCMS OCH2CFS N OCHS N SO2-WCO-NH'-)1 N
Patent MY-151684-A (MY)
Title: Electrical box assembly for a motorcycle
Inventor: VENKATESAN RAGHAVAN
IPC: B62J9/00
Filed: 2008-01-18
Abstract: THE PRESENT SUBJECT MATTER RELATES TO AN ELECTRICAL BOX ASSEMBLY 101 OF A MOTORCYCLE 100. IN ACCORDANCE WITH ONE EMBODIMENT OF THE PRESENT SUBJECT MATTER, AN ELECTRICAL BOX ASSEMBLY 101 INCLUDES AN ELECTRICAL BOX 105 ADAPTED TO HOUSE PLURALITY OF ELECTRICAL COMPONENTS. THE ELECTRICAL BOX 105 IS MOUNTED ON A MAIN TUBE 120 OF THE CHASSIS OF THE MOTORCYCLE 100, BETWEEN LEFT AND RIGHT FRAMES 125 BY MEANS OF A SINGLE MOUNTING SCREW 135 AND PLURALITY OF ANTI MOVEMENT REGISTERS 140. SELECTIVE ACCESS TO SENSITIVE ELECTRICAL COMPONENTS, LIKE FUSE, IN THE ELECTRICAL BOX 105 IS PROVIDED THROUGH A DETACHABLE SPLIT COVER 185, SCREWLESSLY DISPOSED ON AN OPENING IN THE BOTTOM SURFACE OF THE UTILITY BOX 110.
Patent MY-154593-A (MY)
Title: Halogen-free flame retardant insulated wire
Inventor: YUHEI MAYAMA
IPC: H01B7/04
Filed: 2009-03-10
Abstract: A HALOGEN-FREE FLAME RETARDANT INSULATED WIRE (1) IS PROVIDED, WHICH CAN REDUCE A LEAKAGE CURRENT AT HIGH FREQUENCIES AND HIGH VOLTAGES, WHICH SATISFIES REQUIRED CHARACTERISTICS RELATED TO THE FLAME RETARDANCY AND THE FLEXIBILITY, AND WHICH IS USEFUL FOR A REDUCTION IN ENVIRONMENTAL LOAD. THE ABOVE-DESCRIBED WIRE IS A HALOGEN-FREE FLAME RETARDANT INSULATED WIRE (1) CHARACTERIZED BY INCLUDING A CONDUCTOR, A FIRST INSULATED LAYER COVERING THE CONDUCTOR, AND A SECOND INSULATED LAYER COVERING THE FIRST INSULATED LAYER, WHEREIN THE ABOVE-DESCRIBED FIRST INSULATED LAYER IS FORMED FROM A FIRST RESIN COMPOSITION WHICH CONTAINS 5 TO 70 PARTS BY MASS OF NITROGEN SERIES FLAME RETARDANT RELATIVE TO 100 PARTS BY MASS OF RESIN COMPONENT CONTAINING 20 TO 50 PARTS BY MASS OF POLYESTER, 20 TO 50 PARTS BY MASS OF POLYPHENYLENE ETHER, AND 30 TO 60 PARTS BY MASS OF COMPONENT HAVING A RATIO OF STYRENE ELASTOMER TO POLYOLEFIN OF 0:100 TO 100:0 AND WHICH HAS A DIELECTRIC CONSTANT OF 3.2 OR LESS, AND THE SECOND INSULATED LAYER IS FORMED FROM A SECOND RESIN COMPOSITION CONTAINING 150 TO 250 PARTS BY MASS OF METAL HYDROXIDE RELATIVE TO 100 PARTS BY MASS OF RESIN COMPONENT. (FIG. 1)
Patent OA-11950-A (OA)
Title: Mutual prodrugs of amlodipine and atorvastatin.
Inventor: CHANG GEORGE
IPC: C07D405/14
Filed: 2000-03-20
Abstract: This invention relates to mutual prodrugs of amlodipine and atorvastatin and to pharmaceutical compositions thereof. This invention also relates to methods of treating angina pectoris, atherosclerosis, and hypertension and hyperlipidemia in a mammal using those prodrugs and compositions. This invention also relates to methods of managing cardiac risk in a mammal, including humans, presenting with symptoms of cardiac risk by administering those prodrugs and compositions.
Patent OA-12734-A (OA)
Title: Quinazoline derivatives for the treatment of abnormal cell growth.
Inventor: CONNELL RICHARD DAMIAN
IPC: C07D401/12
Filed: 2002-11-04
Abstract: This invention relates to quinazoline derivatives that are usefulin the treatment of abnormal cell growth, such as cancer, in mammals. This invention also relates to a method of using such small molecules in the treatment of abnormal cell growth in mammals, especially humans, and to pharmaceutical compositions containing such compounds. The invention further relates to small molecules that are selective for erbB2 receptor over the erbB1 receptor, wherein said erbB2 inhibitor has a range of selectivities for erbB2 over erbB1 between 50-1500.
Patent RU-2004106150-A (RU)
IPC: C08F6/00
Filed: 2002-07-10
Abstract: The present invention relates to-a process and a device for the continuous manufacture of a polymer of an aromatic alkylene monomer e.g. styrene comprising a bulk polymerisation of the monomer and a devolatilization of the resulting polymer in at least two successive steps so as to separate the polymer from the unreacted monomer and the oligomers formed during the polymerisation. The process comprises conveying a first gas stream resulting from the first step of the devolatilization into a first zone Z 1 for direct condensation and fractionation, removing a gas stream G 1 comprising essentially the monomer from the top of Z 1 , and removing a liquid stream L 1 rich in oligomers from the bottom of Z 1 , a portion of L 1 being taken, cooled and then returned into Z 1 . It also comprises conveying a second gas stream resulting from the second step of the devolatilization into a second zone Z 2 for direct condensation and fractionation, this zone being also fed with the other portion of L 1 , removing a gas stream G 2 comprising the monomer from the top of Z 2 , and removing a liquid stream L 3 comprising essentially the oligomers from the bottom of Z 2 . The process and the device are particularly suitable for continuously manufacturing a styrene polymer, a styrene copolymer having a high impact strength modified by grafting onto a rubber, an expandable polystyrene or an expanded polystyrene. The invention is useful for improving the separation of the unreacted monomer from the oligomers and the quality of the polymer when the unreacted monomer thus separated is recycled e.g. to the polymerisation.
Patent RU-2005101348-A (RU)
IPC: A61K47/48
Filed: 2003-06-20
Abstract: The invention concerns a preparation comprising a plurality of Factor VII polypeptides or Factor VII-related polypeptides, wherein the polypeptides comprise asparagine-linked and/or serine-linked oligosaccharide chains, and wherein at least one oligosaccharide group is covalently attached to at least one polymeric group. The polymeric group could be a polyalkylen oxide (PAO) e.g. polyethylene glycol (PEG).
Patent RU-2006113705-A (RU)
IPC: H01F38/14
Filed: 2004-09-20
Abstract: For a liquid-, or gas-, sensor composed of a sensor module SM and a sensor module head SMK, which are pluggably connectable together and which enable when plugged together an exchange of data and energy via a galvanically decoupled, transfer zone, a pluggable module ST1, or ST2, as the case may be, is provided, which is connectable with the sensor module SM, or with the sensor module head SMK, and which serves for display of sensor data stored in the sensor module SM, or for simulation of a measured value.
Patent RU-2006134847-A (RU)
Title: Уровень транскрипции гена dapk1 в качестве диагностического маркера плоскоклеточного рака легких, применение уровня транскрипции гена dapk1 для диагностики плоскоклеточного рака легких, способ диагностики плоскоклеточного рака легких и набор праймеров для определения уровня транскрипции гена dapk1
IPC: G01N33/48
Filed: 2006-10-03
Abstract: 1. Маркер для диагностики плоскоклеточного рака легких, представляющий собой уровень транскрипции гена DAPK1, где сниженный уровень в предположительно пораженной раком ткани человека по сравнению с ее уровнем в здоровой ткани служит диагностическим признаком плоскоклеточного рака легких.2. Применение уровня транскрипции гена DAPK1 в качестве маркера для диагностики плоскоклеточного рака легких человека.3. Способ диагностики плоскоклеточного рака легких, включающий следующие стадии:а) получение исходной пары образцов ткани от пациента, где один из образцов получен из предположительно пораженной раком ткани, а второй получен из прилегающей гистологически нормальной (условно-нормальной) ткани;б) выделение и очистка препаратов РНК из исходной пары образцов;в) синтез одноцепочечной или двуцепочечной кДНК на матрице РНК с использованием олигонуклеотидных праймеров;г) нормирование концентрации кДНК DAPK1 по контрольному гену, уровень транскрипции которого постоянен в норме и при раке легких;д) проведение количественной или полуколичественной реакции амплификации фрагмента гена DAPK1 с использованием кДНК, полученной на стадии в), в качестве матрицы и пары геноспецифичных олигонуклестидных праймеров;е) сравнение количества амплифицированного фрагмента ДНК DAPK1 для образца, полученного из предположительно пораженной раком ткани, с количеством амплифицированного фрагмента ДНК для образца, полученного из нормальной ткани, где указанные количества амплифицированного фрагмента ДНК отражают уровень транскрипции гена DAPK1, причем уменьшение транскрипции гена DAPK1 служит диагностическим признаком плоскоклеточного рак�